Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease

IMPORTANCE: A reliable method of detecting Alzheimer disease (AD) in its prodromal state is needed for patient stratification in clinical trials or for personalizing existing or potential upcoming therapies. Current cerebrospinal fluid (CSF)– or imaging-based single biomarkers for AD offer reliable...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Neurol
Hlavní autoři: Lehallier, Benoit, Essioux, Laurent, Gayan, Javier, Alexandridis, Roxana, Nikolcheva, Tania, Wyss-Coray, Tony, Britschgi, Markus
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5214993/
https://ncbi.nlm.nih.gov/pubmed/26659895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2015.3135
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky